8 results about "Lost appetite" patented technology

The application provides a traditional Chinese medicine composition for treating diarrhea, and relates to the technical field of traditional Chinese medicine pharmacy. The application provides a traditional Chinese medicine composition for treating chronic diarrhea, which is prepared from madder, yuyulang, camphor tree bark, white peony root, jujube, licorice, lily, trichosanthes root and heron herb. The drugs are used together to have the functions of tonifying the spleen and stomach, astringing the lung to stop diarrhea and warming the middle and promoting qi. The traditional Chinese medicine composition can effectively relieve and improve the clinical symptoms of patients with chronic diarrhea, such as diarrhea, loss of appetite, lassitude and fatigue, and has a remarkable curative effect, so it is worthy of further clinical promotion and application.

The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating co-disease of liver depression and spleen deficiency type depressive state and IBS (irritable bowel syndrome). The composition comprises radix pseudostellariae, poria cocos, raw coix seeds, fingered citron, polygala tenuifolia, roasted rhizoma atractylodis macrocephalae, lotus seed pulp, mint, roses, lilies, raw fructus gardeniae, fermented soybeans and raw hawthorn fruits. Liver soothing, depression relieving, spleen strengthening and heart nourishing are taken as core treatment rules, heat clearing, restlessness relieving, digestion promoting and stagnation removing are also taken, and the complex pathogenesis that the two are causal to each other is formed for gastrointestinal dysfunction caused by emotional discomfort. The formula is characterized in that the three internal organs of the heart, the liver and the spleen are treated at the same time, the four methods of tonifying, dredging, clearing and eliminating are used at the same time, balance is achieved between qi regulating and healthy qi supporting, and the formula is suitable for patients suffering from complex heart and body diseases with low mood, anxiety, dysphoria, insomnia, amnesia, abdominal fullness, inappetence, loose stool or loose stagnation.

The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition with kidney tonifying and bowel relaxing functions and a preparation method, a preparation and application thereof. The traditional Chinese medicine composition comprises the following components: wine-processed cistanche, angelica sinensis, cooked rhubarb, semen cassiae, achyranthes bidentata, radix paeoniae alba, pericarpium citri reticulatae, rhizoma alismatis, fructus aurantii and rhizoma cimicifugae. The traditional Chinese medicine composition provided by the invention is mainly used for warming the kidney, boosting essence and relaxing bowel. The traditional Chinese medicine is used for treating dry stool, constipation due to intestinal dryness, clear and long urine, soreness and weakness of waist and knees, general weakness, stomachache, abdominal distension, blood deficiency and sallow yellowness, insomnia, headache and dizziness, spontaneous perspiration and inappetence caused by kidney deficiency and body fluid deficiency; the traditional Chinese medicine is used for treating irritable bowel syndrome and menstrual disorder.

The application provides a patchouli composition for removing dampness, invigorating the spleen, refreshing the brain and calming the nerves and a preparation method and application thereof, and belongs to the technical field of functional food. The composition comprises the following raw materials: patchouli, 10-20 parts; tuckahoe, 8-18 parts; bergamot, 5-15 parts; dried tangerine or orange peel, 3-10 parts; and fried licorice, 2-6 parts. The application takes five kinds of food-medicine homologous materials, namely, patchouli, tuckahoe, bergamot, dried tangerine or orange peel and fried licorice, as core effective components, realizes the synergistic effects of removing dampness and turbidity, invigorating the spleen and stomach, soothing the liver and regulating qi, refreshing the brain and calming the nerves through scientific proportioning, and can be prepared into various edible dosage forms such as granules, oral liquid and ointment, and is especially suitable for modern sub-healthy people with heavy dampness, weak spleen and stomach, emotional irritability, dizziness, poor appetite and heavy limbs, is mild and safe, has no side effects, is suitable for long-term conditioning, and belongs to the technical field of functional conditioning food with food-medicine homology.

Provided herein are compositions comprising a non-naturally occurring melanocortin analogue in combination with a spiro compound and / or an antibody or antigen-binding fragment thereof. The composition may further include an anti-cancer agent (e.g., a chemotherapeutic agent). Also provided herein are pharmaceutical compositions incorporating the compositions; methods of using the compositions to modulate weight, including but not limited to increasing appetite, preventing inappetence, promoting weight gain, preventing weight loss, and / or treating, preventing, or otherwise reducing cachexia and / or anorexia in a subject in need thereof.

The present invention relates to a pharmaceutical composition for preventing, ameliorating, or treating anorexia and weight loss, comprising a Bupleuri Radix extract. Specifically, the present invention provides a pharmaceutical composition having effects in preventing, ameliorating, or treating anorexia and weight loss, wherein a Bupleuri Radix extract increases ghrilin, which is a hormone that stimulates appetite, and decreases TPH1(I), which is a serotonin synthase. In addition, a health functional food for preventing or ameliorating anorexia and weight loss, comprising a Bupleuri Radix extract, can be developed, and the extract can be effectively used for the treatment and the development of therapeutic agents for anorexia induced by chemotherapy in the future.

This invention relates to the field of veterinary preventive and therapeutic drugs. The invention provides a traditional Chinese medicine composition for the prevention and / or treatment of porcine reproductive and respiratory syndrome (PRRS) and its preparation method, comprising the following components: Indigo naturalis, Forsythia suspensa, Arctium lappa, Dryopteris crassirhizoma, Lithospermum erythrorhizon, Taraxacum mongolicum, Rheum palmatum, Scutellaria barbata, Glycyrrhiza uralensis, Hordeum vulgare, Bupleurum chinense, and Terminalia chebula. The invention also provides a traditional Chinese medicine preparation comprising the aforementioned composition. Using the above-mentioned components in combination with the technical solution of this invention can effectively enhance the inhibitory effect on pathogenic microorganisms and the anti-PRRSV virus effect, improve immunity, and enhance the disease resistance of pigs; alleviate symptoms such as depression and loss of appetite caused by PRRSV, and regulate the gastrointestinal health of animals; at the same time, it has few toxic side effects and is less likely to induce drug resistance.

This invention discloses a tumor adjuvant nutritional preparation based on *Pterocarya stenoptera* oil, its preparation method, and its application. The active ingredients of this preparation are composed of *Pterocarya stenoptera* oil, ω-3 fatty acids, and arginine in a mass ratio of (1-3):(1-2):(1-2), preferably 2:1:1. The preparation method includes mixing the above components evenly, followed by high-pressure homogenization and aseptic emulsification to produce an oral liquid, enteral nutrition emulsion, or powder. This preparation can effectively improve chemotherapy-induced bone marrow suppression, significantly increase white blood cell, red blood cell, and hemoglobin levels, enhance serum superoxide dismutase activity, reduce oxidative stress damage, and significantly alleviate gastrointestinal adverse reactions such as nausea, vomiting, and loss of appetite in cancer patients undergoing radiotherapy and chemotherapy, improving patients' nutritional status and quality of life, and exhibiting good safety.